{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:34:26Z","timestamp":1773930866224,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Brainstem metastases (BSM) are associated with a poor prognosis and their management represents a therapeutic challenge. BSM are often inoperable and, in absence of randomized trials, the optimal radiation treatment of BSM remains to be defined. We evaluated the efficacy and toxicity of linear accelerator (linac)-based stereotactic radiosurgery (SRS) and hypofractionated steretotactic radiotherapy (HSRT) in the treatment of BSM in a series of patients treated in different clinical centers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a multicentric retrospective study of patients affected by 1\u20132 BSM from different histologies who underwent SRS\/HSRT. Freedom from local progression (FLP), cancer-specific survival (CSS), overall survival (OS), and treatment-related toxicity were evaluated. In addition, predictors of treatment response and survivals were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Between 2008 and 2021, 105 consecutive patients with 111 BMS who received SRS or HSRT for 1\u20132 BSM were evaluated. Median follow-up time was 10\u00a0months (range 3\u2013130). One-year FLP rate was 90.4%. At the univariate analysis, tumor volume\u2009\u2264\u20090.4\u00a0cc, and concurrent targeted therapy were associated with longer FLP, with combined treatment that remained a significant independent predictor [0.058, HR 0.139 (95% CI 0.0182\u20131.064]. Median OS and CSS were 11\u00a0months and 14.6\u00a0months, respectively. At multivariate analysis, concurrent targeted therapy administration was significantly associated with longer OS [HR 0.514 (95%CI 0.302\u20130.875); p\u2009=\u20090.01]. Neurological death occurred in 30.4% of patients, although this was due to local progression in only 3 (2.8%) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Linac-based SRS\/HSRT offers excellent local control to patients with BSM, with low treatment-related toxicity and no apparent detrimental effects on OS. When treated with ablative intent, BSM are an uncommon cause of neurological death. The present results indicates that patients with BSM should not be excluded a priori from clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-022-02111-5","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:03:19Z","timestamp":1660046599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study"],"prefix":"10.1186","volume":"17","author":[{"given":"Luca","family":"Nicosia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Giraffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Tini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"2111_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70061-0","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014. https:\/\/doi.org\/10.1016\/S1470-2045(14)70061-0.","journal-title":"Lancet Oncol"},{"key":"2111_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02550-0","author":"F Alongi","year":"2021","unstructured":"Alongi F, Nicosia L, Figlia V, et al. Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique. Clin Transl Oncol. 2021. https:\/\/doi.org\/10.1007\/s12094-020-02550-0.","journal-title":"Clin Transl Oncol"},{"key":"2111_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70263-3","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3.","journal-title":"Lancet Oncol"},{"key":"2111_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(99)00507-6","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305. Int J Radiat Oncol Biol Phys. 2000. https:\/\/doi.org\/10.1016\/S0360-3016(99)00507-6.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR5","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000325726.72815.22","author":"MS Sharma","year":"2008","unstructured":"Sharma MS, Kondziolka D, Khan A, et al. Radiation tolerance limits of the brainstem. Neurosurgery. 2008. https:\/\/doi.org\/10.1227\/01.NEU.0000325726.72815.22.","journal-title":"Neurosurgery"},{"key":"2111_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.08.078","author":"C Mayo","year":"2010","unstructured":"Mayo C, Yorke E, Merchant TE. Radiation Associated Brainstem Injury. Int J Radiat Oncol Biol Phys. 2010. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.08.078.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR7","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.79.5.0661","author":"S Somaza","year":"1993","unstructured":"Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC. Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg. 1993. https:\/\/doi.org\/10.3171\/jns.1993.79.5.0661.","journal-title":"J Neurosurg"},{"key":"2111_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9458-4","author":"N Kased","year":"2008","unstructured":"Kased N, Huang K, Nakamura JL, et al. Gamma knife radiosurgery for brainstem metastases: the UCSF experience. J Neurooncol. 2008. https:\/\/doi.org\/10.1007\/s11060-007-9458-4.","journal-title":"J Neurooncol"},{"key":"2111_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1750","author":"SA Koyfman","year":"2010","unstructured":"Koyfman SA, Tendulkar RD, Chao ST, et al. Stereotactic radiosurgery for single brainstem metastases: The Cleveland clinic experience. Int J Radiat Oncol Biol Phys. 2010. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1750.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR10","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31821d31de","author":"MA Hatiboglu","year":"2011","unstructured":"Hatiboglu MA, Chang EL, Suki D, Sawaya R, Wildrick DM, Weinberg JS. Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery. Neurosurgery. 2011. https:\/\/doi.org\/10.1227\/NEU.0b013e31821d31de.","journal-title":"Neurosurgery"},{"key":"2111_CR11","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31823c40fe","author":"CS Lin","year":"2012","unstructured":"Lin CS, Selch MT, Lee SP, et al. Accelerator-based stereotactic radiosurgery for brainstem metastases. Neurosurgery. 2012. https:\/\/doi.org\/10.1227\/NEU.0b013e31823c40fe.","journal-title":"Neurosurgery"},{"key":"2111_CR12","doi-asserted-by":"publisher","DOI":"10.3171\/2012.7.gks12977","author":"T Kawabe","year":"2012","unstructured":"Kawabe T, Yamamoto M, Sato Y, et al. Gamma Knife surgery for patients with brainstem metastases. J Neurosurg. 2012. https:\/\/doi.org\/10.3171\/2012.7.gks12977.","journal-title":"J Neurosurg"},{"key":"2111_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1086-6","author":"M \u015eeng\u00f6z","year":"2013","unstructured":"\u015eeng\u00f6z M, Kabalay IA, Tezcanli E, Peker S, Pamir N. Treatment of brainstem metastases with gamma-knife radiosurgery. J Neurooncol. 2013. https:\/\/doi.org\/10.1007\/s11060-013-1086-6.","journal-title":"J Neurooncol"},{"key":"2111_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15069748","author":"HE Peterson","year":"2014","unstructured":"Peterson HE, Larson EW, Fairbanks RK, et al. Gamma knife treatment of brainstem metastases. Int J Mol Sci. 2014. https:\/\/doi.org\/10.3390\/ijms15069748.","journal-title":"Int J Mol Sci"},{"key":"2111_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1373-x","author":"JM Kilburn","year":"2014","unstructured":"Kilburn JM, Ellis TL, Lovato JF, et al. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: Is there a volume threshold for toxicity? J Neuro-Oncol. 2014. https:\/\/doi.org\/10.1007\/s11060-014-1373-x.","journal-title":"J Neuro-Oncol."},{"key":"2111_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npu032","author":"KR Voong","year":"2015","unstructured":"Voong KR, Farnia B, Wang Q, et al. Gamma knife stereotactic radiosurgery in the treatment of brainstem metastases: the MD anderson experience. Neuro-Oncology Pract. 2015. https:\/\/doi.org\/10.1093\/nop\/npu032.","journal-title":"Neuro-Oncology Pract."},{"key":"2111_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-003-0034","author":"T Shuto","year":"2003","unstructured":"Shuto T, Fujino H, Asada H, Inomori S, Nagano H. Gamma knife radiosurgery for metastatic tumours in the brain stem. Acta Neurochir (Wien). 2003. https:\/\/doi.org\/10.1007\/s00701-003-0034.","journal-title":"Acta Neurochir (Wien)"},{"key":"2111_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2009.03.003","author":"L Davidson","year":"2009","unstructured":"Davidson L, Zada G, Yu C, et al. Delayed toxicity from gamma knife radiosurgery to lesions in and adjacent to the brainstem. J Clin Neurosci. 2009. https:\/\/doi.org\/10.1016\/j.jocn.2009.03.003.","journal-title":"J Clin Neurosci"},{"key":"2111_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.surneu.2008.01.029","author":"JG Lorenzoni","year":"2009","unstructured":"Lorenzoni JG, Devriendt D, Massager N, et al. Brain stem metastases treated with radiosurgery: prognostic factors of survival and life expectancy estimation. Surg Neurol. 2009. https:\/\/doi.org\/10.1016\/j.surneu.2008.01.029.","journal-title":"Surg Neurol"},{"key":"2111_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-107","author":"JE Leeman","year":"2012","unstructured":"Leeman JE, Clump DA, Wegner RE, Heron DE, Burton SA, Mintz AH. Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases. Radiat Oncol. 2012. https:\/\/doi.org\/10.1186\/1748-717X-7-107.","journal-title":"Radiat Oncol"},{"key":"2111_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.02.028","author":"CA Valery","year":"2011","unstructured":"Valery CA, Boskos C, Boisserie G, et al. Minimized doses for linear accelerator radiosurgery of brainstem metastasis. Int J Radiat Oncol Biol Phys. 2011. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.02.028.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1262","author":"WC Chen","year":"2021","unstructured":"Chen WC, Baal UH, Baal JD, et al. Efficacy and safety of stereotactic radiosurgery for brainstem metastases: a systematic review and meta-analysis. JAMA Oncol. 2021. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1262.","journal-title":"JAMA Oncol"},{"key":"2111_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70057-4","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, et al. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol. 2015. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4.","journal-title":"Lancet Oncol"},{"key":"2111_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.06.009","author":"DM Trifiletti","year":"2016","unstructured":"Trifiletti DM, Lee CC, Kano H, et al. Stereotactic radiosurgery for brainstem metastases: an international cooperative study to define response and toxicity. Int J Radiat Oncol Biol Phys. 2016. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.06.009.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.10.034","author":"KJ Redmond","year":"2021","unstructured":"Redmond KJ, Gui C, Benedict S, et al. Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2021. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.10.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2111_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-019-10004-3","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Figlia V, Mazzola R, et al. Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArcTM) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis. Clin Exp Metastasis. 2020. https:\/\/doi.org\/10.1007\/s10585-019-10004-3.","journal-title":"Clin Exp Metastasis"},{"key":"2111_CR27","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.500","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Figlia V, Giaj-Levra N, Minniti G, Alongi F. Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases is it time to give up whole-brain radiotherapy? Oncoscience. 2020. https:\/\/doi.org\/10.18632\/oncoscience.500.","journal-title":"Oncoscience"},{"key":"2111_CR28","doi-asserted-by":"publisher","unstructured":"Sambl\u00e1s JM, Sallabanda K, Bustos JC, et al. Radiosurgery and whole brain therapy in the treatment of brainstem metastases. Clin Transl Oncol. 2009;11(10):677\u201380. https:\/\/doi.org\/10.1007\/s12094-009-0423-x.","DOI":"10.1007\/s12094-009-0423-x"},{"key":"2111_CR29","doi-asserted-by":"publisher","unstructured":"Kelly PJ, Lin YB, Yu AY, et al. Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber\/Brigham and Women's Cancer Center experience. J Neurooncol. 2011;104(2):553-7. https:\/\/doi.org\/10.1007\/s11060-010-0514-0.","DOI":"10.1007\/s11060-010-0514-0"},{"key":"2111_CR30","doi-asserted-by":"publisher","unstructured":"Sugimoto T, Matsuda R, Tamamoto T, et al. Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for brainstem metastasis. World Neurosurg. 132e680-e686, S1878875019322041. https:\/\/doi.org\/10.1016\/j.wneu.2019.08.049.","DOI":"10.1016\/j.wneu.2019.08.049"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02111-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-022-02111-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-022-02111-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:09:17Z","timestamp":1660046957000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-022-02111-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2111"],"URL":"https:\/\/doi.org\/10.1186\/s13014-022-02111-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}